Canadian study shows success of treatment for blood clots connected with AstraZeneca’s COVID-19 vaccination
2021-06-10 from theglobeandmail.com
With more than 80 per cent of the world’s population still unprotected against COVID-19, a team of Canadian researchers has documented a successful treatment for blood clots associated with the Oxford-AstraZeneca vaccine, a crucial weapon in the global effort to combat the pandemic.
The results provide confidence that the clotting can be arrested if caught in time. However, they do not entirely eliminate the possibility of death or serious complications related to the rare condition known as vaccine-induced immune thrombotic thrombocytopenia, or VITT.
In a study published Wednesday in the New England Journal of Medicine, a team led by researchers at McMaster University in Hamilton, Ont., reported on the treatment of three Canadian patients who developed VITT. Each patient received a combined therapy consisting of antibodies delivered intravenously along with anticoagulants.
Read more here